Target intelligence / Profile preview

Gut microbiota ecosystem

Molecular classification
Other (microbial/communal ecosystem)
01

Overview

The gut microbiota ecosystem is the vast and dynamic community of microorganisms—including bacteria, archaea, viruses, and eukaryotes (primarily fungi)—inhabiting the gastrointestinal tract of humans and animals[1][2][4]. This microbial community interacts closely with the host, playing essential roles in digestion, metabolism, immune system development, pathogen resistance, and other aspects of health. A balanced and diverse microbiota is associated with optimal health, whereas disruptions in its composition (dysbiosis) are linked to diseases such as IBD, obesity, metabolic syndrome, and neuropsychiatric disorders[6][7]. The ecosystem changes with age, diet, environment, and medication use, and is highly individualized. Unlike a classical molecular drug target, the gut microbiota is a diverse ecosystem that can be influenced by drugs (antibiotics, probiotics, etc.) but is not a single molecule or protein[3][6]. In summary, the "gut microbiota ecosystem" is an entire communal system, not an individual molecular target. It is essential for homeostasis and health, can be manipulated for therapeutic purposes (e.g. FMT, antibiotics), but does not fit the conventional definition of a molecular receptor or target.

Other names
Gut microbiotagut microbiomegut floragastrointestinal microbiota
02

Mechanism of action

Alteration (suppression, elimination, or modulation) of microbial composition (e.g., antibiotics eliminate or inhibit portions of microbiota); Introduction or support of beneficial organisms (probiotics, FMT); Stimulation of beneficial species via substrate provision (prebiotics); Selective pressure modifying function or diversity; Indirect modulation of immune function or metabolism

03

Biological functions

Energy harvesting from dietary substratesMetabolizing and synthesizing vitamins (e.g., vitamin K, B vitamins)Immune system development and regulationMaintenance of gut barrier functionResistance to colonization by pathogensProduction of short-chain fatty acids and other metabolitesModulation of the gut-brain axis
04

Disease associations

ObesityInflammatory bowel disease (IBD)DiabetesCardiovascular diseaseNeuropsychiatric disease (e.g. anxiety, depression)CancerInfections (e.g., C. difficile colitis)Other (gut dysbiosis associated pathologies)
05

Safety considerations

Antibiotic resistanceMicrobiota disruption (dysbiosis), leading to infections or metabolic disordersPathogen transmission with FMTUnexpected immune effects with microbiota-targeting interventionsLong-term safety of prebiotic/probiotic supplementation is not fully established
06

Interacting drugs

Antibiotics (broad-spectrum and narrow-spectrum)

5 more in the full profile.

07

Biomarkers

Specific microbial species abundance (e.g., Faecalibacterium prausnitzii for gut health)Microbial gene richness/diversity indicesMicrobial metabolite levels (e.g., short-chain fatty acids)Presence/absence of pathogens (e.g., Clostridioides difficile)Microbiota-derived molecular signatures

Beyond the preview

Go deeper on Gut microbiota ecosystem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota ecosystem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call